The influence of variables that might affect the accuracy of pulse oximetry (SpO 2 ) recordings in critically ill patients is not well established. We sought to describe the relationship between paired SpO 2 /SaO 2 (oxygen saturation via arterial blood gas analysis) in adult intensive care unit (ICU) patients and to describe the diagnostic performance of SpO 2 in detecting low SaO 2 and PaO 2 . A paired SpO 2 /SaO 2 measurement was obtained from 404 adults in ICU. Measurements were used to calculate bias, precision, and limits of agreement. Associations between bias and variables including vasopressor and inotrope use, capillary refill time, hand temperature, pulse pressure, body temperature, oximeter model, and skin colour were estimated. There was no overall statistically significant bias in paired SpO 2 /SaO 2 measurements; observed limits of agreement were +/-4.4%. However, body temperature, oximeter model, and skin colour, were statistically significantly associated with the degree of bias. SpO 2 <89% had a sensitivity of 3/7 (42.9%; 95% confidence intervals, CI, 9.9% to 81.6%) and a specificity of 344/384 (89.6%; 95% CI 86.1% to 92.5%) for detecting SaO 2 <89%. The absence of statistically significant bias in paired SpO 2 /SaO 2 in adult ICU patients provides support for the use of pulse oximetry to titrate oxygen therapy. However, SpO 2 recordings alone should be used cautiously when SaO 2 recordings of 4.4% higher or lower than the observed SpO 2 would be of concern. A range of variables relevant to the critically ill had little or no effect on bias.
1
. The United States Food and Drug Administration requires pulse oximeters to be tested for accuracy with simultaneous recordings of arterial oxygen saturation measured with pulse oximetry (SpO 2 ) and by arterial blood gas analysis (SaO 2 ) 2 . However, these validation studies can be conducted with healthy volunteers 2 and their findings may not apply to critically ill patients. While SpO 2 monitoring is used routinely to guide titration of oxygen therapy in the intensive care unit (ICU) 3 , there are only a few studies that report data about the accuracy of pulse oximeter measurements in adult ICU patients. These small studies have assessed agreement between SpO 2 and SaO 2 in acutely ill patients [4] [5] [6] [7] [8] [9] [10] , and report important bias in the mean difference between SpO 2 and SaO 2 4,5 as well as wide limits of agreement [4] [5] [6] . A limitation of many of these studies is that they used a variable number of measurements from individual patients. Because agreement between SpO 2 and SaO 2 recordings might vary between individuals, this may have resulted in systematic bias in the results reported. An additional issue in relation to the ICU population is that the effects of potentially confounding factors that might affect the accuracy of pulse oximeter measurements in ICU patients in particular, including vasopressor use and capillary refill, are not well understood 4, 8 . Overall, the accuracy of SpO 2 recordings is not well established in critically ill patients where the confounding factors mentioned above are commonly present [4] [5] [6] and the diagnostic performance of pulse oximetry to detect low arterial oxygen levels in critically ill patients is uncertain [4] [5] [6] [7] .
The focus of this study was to address these knowledge deficits to provide evidence supporting the use of SpO 2 monitoring to guide clinical decision-making in the ICU. Specifically, we aimed to evaluate the performance of pulse oximeters used in one Australian ICU and one New Zealand ICU, with respect to the following three specific objectives: 1) to describe the relationship between paired SpO 2 and SaO 2 measurements in ICU patients in terms of bias and limits of agreement, 2) to estimate the influence on bias of various clinical variables relevant to the critically ill, and 3) to describe the diagnostic performance of SpO 2 recordings in relation to low arterial oxygen saturation (SaO 2 <89%) and low arterial oxygen tension (PaO 2 ) (PaO 2 <60 mmHg).
Materials and methods

Study design, setting, and participants
We conducted a bi-national prospective cohort study, evaluating simultaneous SpO 2 and SaO 2 recordings in ICU patients. Recruitment took place at Wellington Hospital ICU (Wellington, New Zealand) from June 2015 to October 2015, and at the Austin Hospital (Victoria, Australia) from November 2015 to April 2016. Consecutive patients admitted to each ICU were included provided they had routine pulse oximeter monitoring and arterial blood gas sampling performed as part of usual clinical care. All arterial blood gases were measured using the alphastat method (normalising to 37°C) and were performed immediately after sampling. Patients were excluded if they had methaemoglobinaemia, had received intravenous dye (such as methylene blue) during the current admission, had a diagnosis of carbon monoxide poisoning, were aged <16 years, or where the patient had previously been recruited into the study.
Study variables and methods of data collection
Descriptive data Demographic data including age, gender, and ethnicity were collected from clinical notes and electronic paper records. Admission diagnosis and illness severity were recorded based on the Acute Physiology and Chronic Health Evaluation (APACHE) II 11 . Ventilation status and receipt of vasopressors and/or inotropes were also recorded. At the time of arterial blood gas sampling SpO 2 and SaO 2 measurements A single paired SpO 2 and SaO 2 measurement was obtained from each participant. This pair of measurements was taken at least two hours after ICU admission to allow for initial adjustments in ventilator settings to be made. The SpO 2 value recorded was the first value displayed by pulse oximetry following visualisation of the blood entering the blood gas syringe. In both study centres arterial blood gas analysis was performed using a Radiometer ABL 800 FLEX arterial blood gas analyser (Brønshøj, Denmark). Pulse oximeters in Wellington ICU were Marquette Rac-4A monitors (GE Healthcare, Chicago, IL, USA) with Masimo (Irvine, CA, USA) sensors while oximeters in Austin ICU were Philips IntelliVue MP70 monitors (Amsterdam, Netherlands) with Philips Adult Reusable SpO 2 sensors. In both ICUs pulse oximetry recordings were taken from the ear, finger or toe with the site of monitoring at the clinical discretion of the ICU staff and the site of monitoring was documented. The timing of the paired SpO 2 and SaO 2 measurements relative to ICU admission time was recorded.
Variables potentially affecting the relationship between PaO 2 and SpO 2
The pre-specified potential predictors of the relationship between PaO 2 and SpO 2 and the timings of these measurements and the methods used to capture and categorise each potential predictor are shown in Table 1 .
Statistical methods
A sample size of 400 participants was chosen based on a number of considerations. Firstly, for the analysis of variables that potentially predicted bias we sought to have between 20 and 40 participants for each degree of freedom in the analysis of covariance for the exploration of predictor variables. Secondly, based on reported paired standard deviations for the SpO 2 to SaO 2 difference of 2.1% 6 and 2.2%
12 from previous studies we sought to have sufficient power to detect a difference of 2% for any variables that might predict bias. If there were two equal sized groups of 42 participants, 21 in each group, there would be 80% power with a type 1 error rate of 5% to detect this size difference. Thus, for groups with at least 20 participants with a particular characteristic, our study provides greater than 80% power to detect a difference of 2% between groups for dichotomous variables.
Paired SpO 2 and SaO 2 measurements were examined using the method of Bland et al 13 to calculate bias (difference in means, d), standard deviation (SD) of the differences (precision, s) and limits of agreement (d ± 2s). The statistical significance of the bias was estimated with a paired Student's t-test. Spearman's correlation coefficient was used to assess if there was an association between the difference and the mean saturation. Associations between the bias (SaO 2 minus SpO 2 ) and other variables were estimated by simple linear regression for continuous variables and analysis of variance for categorical variables. For the variables that were strongly associated with bias, general linear models (i.e. analysis of covariance) were used to model the bias for each level of these variables together with the 95% confidence intervals (CI) for an individual prediction which was used to estimate the limits of agreement within these variable levels.
Contingency tables were used to illustrate sensitivity and specificity together with 95% CI for these proportions of SpO 2 for detecting an SaO 2 of <89% and a PaO 2 <60 mmHg. Logistic regression was used to estimate a receiver operator characteristic curve of SpO 2 against an SaO 2 of <89% and against a PaO 2 of <60 mmHg. SAS Version 9.4 was used (SAS Institute Inc).
Ethics approval
Prospective approval was obtained from the New Zealand Northern A Health and Disability Ethics Committee (reference number 14/NTA/180) and in Australia from the Austin Health Human Research Ethics Committee (reference number LNR/15/Austin/253). Written informed consent was not required for this observational study; however, participants or relatives were provided written information and given the opportunity to opt out of having data included in the study.
Results
Study population
We enrolled 404 participants. Two were excluded due to the participant or relative opting out of the study and eight were excluded due to the paired SpO 2 and SaO 2 measurements inadvertently being recorded within two hours of admission to ICU. The remaining 394 participants, of whom 196 (49.7%) were from Wellington ICU and 198 (50.3%) were from the Austin ICU, were included in the analysis (Figure 1) . A broad range of ICU patients were included with 212/394 (53.8%) admitted to the ICU postoperatively ( Table 2 ). The mean (SD) SpO 2 was 95.6% (3.0%) with 349/381 (91.6%) of pulse oximetry readings measured with a finger probe (Table 3) .
Agreement between SpO 2 and SaO 2 measurements
There was no statistically significant bias in paired measurements of SpO 2 and SaO 2 . The difference in mean for SaO 2 minus SpO 2 (95% CI) was 0.15% (-0.07% to 0.36%; P=0.18). The standard deviation of the differences was 2.2% (95% CI 2.0% to 2.3%) indicating limits of agreement of plus or minus 4.4%. The size of the SaO 2 minus SpO 2 difference was associated with the mean saturation, defined as (SaO 2 + SpO 2 )/2; Spearman correlation coefficient of -0.20, P <0.001, consistent with a tendency for SpO 2 to underestimate SaO 2 at 
Potential predictors affecting the relationship between SpO 2 and SaO 2
PaO 2 , body temperature, pulse oximeter model, skin colour, and the presence of a local factor interfering with the pulse oximeter recording were the only variables significantly associated with the size of the difference between SpO 2 and SaO 2 ( Table 4) 
Diagnostic performance of the SpO 2
A value of SpO 2 <89% had a sensitivity of 3/7 (42.9%; 95% CI 9.9% to 81.6%) and a specificity of 344/384 (89.6%; 95% CI 86.1% to 92.5%) for detecting SaO 2 <89%. The C-statistic for the area under the receiver operating curve was 0.92 ( Figure  4 ). Sensitivities and specificities of discrete values for SpO 2 for detecting SaO 2 <89% are provided in the Supplemental Appendix (Table S1 , see website).
A value of SpO 2 <89% had a sensitivity of 6/16 (37.5%; 95% CI 15.2% to 64.6%) and a 89.3% specificity of 335/375 (95% CI 85.8% to 92.3%) for detecting a PaO 2 <60 mmHg. The C-statistic for the area under the receiver operating curve was 0.94 ( Figure S2 , Supplemental Appendix). Sensitivities and specificities of discrete cut-off values for SpO 2 for detecting PaO 2 <60 mmHg are provided in the Supplemental Appendix (Table S2) .
Discussion
In this bi-national prospective cohort study we evaluated the diagnostic performance of SpO 2 compared with SaO 2 in adult ICU patients and found that there was no statistically significant bias in paired measurements of SpO 2 and SaO 2 . The relationship between SpO 2 and SaO 2 recordings was associated with the saturation level with a tendency for SpO 2 to underestimate SaO 2 at low saturations and to overestimate Table 4 Univariate associations for variables potentially affecting the relationship between pulse oximetry and arterial oxygen saturation SpO 2 tends to get larger and a negative coefficient that it gets smaller with an increase in the variable. † Scores on the APACHE II range from 0 to 71, with higher scores indicating more severe disease and a higher risk of death. ‡ The difference is between the first named categorical variable level and the second for the SaO 2 -SpO 2 difference. A positive value means that the SaO 2 is higher than the SpO 2 and a negative value that it is less. CI, confidence intervals; APACHE, Acute Physiology and Chronic Health Evaluation; PaO 2 , arterial oxygen tension; SaO 2 , arterial oxygen saturation; SpO 2 , oxygen saturation on pulse oximetry. SaO 2 at high saturations. Despite the lack of overall bias, the observed limits of agreement were plus or minus 4.4%. This finding is consistent with previous literature 6 and we submit that it represents a clinically important difference in agreement between SpO 2 and SaO 2 readings.
Body temperature, pulse oximeter model, skin colour, and the presence of a local factor interfering with pulse oximeter recording each had statistically significant effects on bias in pulse oximetry recordings. However, the magnitude of these effects was generally small. Our study is the first to evaluate the effect on the relationship between SpO 2 and SaO 2 of a range of variables of particular relevance to the adult ICU population, including mean arterial pressure, pulse pressure, and peripheral perfusion. For all of these variables, no statistically significant effects on bias in pulse oximetry recordings were found. The observed 95% CIs for univariate associations make it unlikely that any of the variables assessed result in clinically important bias in the relationship between SpO 2 and SaO 2 . In contrast to our findings, one previous study suggested a statistically significant association between the use of vasoactive drugs and bias in paired SpO 2 and SaO 2 measurements 6 . However, this previous study 6 finding may represent a type 1 error as only 36 patients were receiving vasoactive drugs compared to 184 patients receiving such drugs in our study.
Because the number of recordings where the SaO 2 was <89% was small, the CIs around our estimates of sensitivity were relatively wide. We also note that because the inspired oxygen concentration is typically increased rapidly in the ICU setting in response to a low SpO 2 3 , our estimates of sensitivity are likely to have been subject to sampling bias. In particular, the proportion of SaO 2 recordings of <89% that were obtained when the SpO 2 was reading ≥90% is likely to have been influenced by such bias. Consequently, while the relatively low sensitivity of a value of SpO 2 below a threshold of 89% for detecting a low SaO 2 observed in our study reflects the diagnostic performance of pulse oximetry in clinical practice, it probably underestimates the true diagnostic performance of the pulse oximeters evaluated.
Our study had a number of strengths. We collected paired SpO 2 and SaO 2 measurements from consecutive adult patients admitted to the ICU and no patients met exclusion criteria so our findings should apply broadly to the spectrum of patients typically encountered in adult ICU practice. Unlike most previous studies 5, 7 , we only collected a single paired specimen from each patient. This approach increases the internal validity of our findings compared to previous studies because it eliminates the potential for confounding arising due to repeated measures from an individual participant.
We performed our study in centres in two different countries that used two different pulse oximeter models. Although we sought to assess the influence of pulse oximeter type on bias, our data do not allow us to distinguish the relative contributions of admission ICU and pulse oximeter type to the bias observed. Furthermore, our findings do not necessarily apply to other pulse oximeters or other ICUs where the case-mix of patients might be different. Because the proportion of patients with various individual local factors potentially interfering with pulse oximetry signals such as false nails 14 , nail polish 15 , motion artefact, or a weak pulse oximeter signal was anticipated to be too small to allow meaningful statistical inferences to be drawn, we chose to pool these various local factors together into a single category. Although we demonstrated that the presence of any local factor interfering with pulse oximetry led to SpO 2 underestimating the SaO 2 by around 1% on average, it is unlikely these factors all have the same effect on bias. We did not document the presence or absence of atrial fibrillation which might have influenced the reliability of the pulse oximetry trace due to associated fluctuations in stroke volume.
The tendency for SpO 2 to underestimate SaO 2 at low saturation levels observed in our study has been shown previously 6 . This tendency should reduce the overall risk of clinically important arterial desaturation when using SpO 2 monitoring. The absence of significant bias in paired SpO 2 and SaO 2 recordings in adult ICU patients provides support for the use of pulse oximetry to titrate oxygen therapy in ICU patients without the need for routine confirmatory measurements of SaO 2 . However, the wide limits of agreement observed suggest, as has been described previously 6 , that SpO 2 recordings alone should be used with <89%. The C-statistic was 0.88. Data were missing from three participants. SpO 2 , oxygen saturation by pulse oximetry; SaO 2 , arterial oxygen saturation.
caution when SaO 2 recordings of between 4.4% higher and lower than the observed SpO 2 measurement would be of clinical concern. Our data indicate that there is a risk of unappreciated arterial oxygen desaturation occurring when inspired oxygen concentrations are reduced to target relatively low SpO 2 levels. Because both hyperoxaemia and hypoxaemia are associated with increased mortality risk 16 , the optimal SpO 2 target for critically ill patients that best balances these risks should be established in randomised controlled trials. 
Declaration of interest
